--- title: "MultiPlan (NYSE:MPLN) Shares to Reverse Split on Monday, September 23rd" description: "MultiPlan Co. (NYSE:MPLN) will execute a 1-for-40 reverse stock split on September 23rd, following an announcement made on September 10th. Shareholders will see their share counts adjusted after the m" type: "news" locale: "en" url: "https://longbridge.com/en/news/214106075.md" published_at: "2024-09-11T23:13:22.000Z" --- # MultiPlan (NYSE:MPLN) Shares to Reverse Split on Monday, September 23rd > MultiPlan Co. (NYSE:MPLN) will execute a 1-for-40 reverse stock split on September 23rd, following an announcement made on September 10th. Shareholders will see their share counts adjusted after the market closes on September 20th. The company has faced financial challenges, reporting a negative EPS and a significant net margin loss in its latest quarterly results. Recent insider trading includes substantial stock purchases by CFO Douglas Michael Garis and CEO Travis Dalton. Institutional investors hold a significant stake in the company, with recent increases in their holdings. MultiPlan Co. (NYSE:MPLN - Free Report) shares are scheduled to reverse split on Monday, September 23rd. The 1-40 reverse split was announced on Tuesday, September 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, September 20th. ## MultiPlan Price Performance Shares of NYSE:MPLN traded down $0.02 during midday trading on Wednesday, hitting $0.22. 4,353,352 shares of the stock were exchanged, compared to its average volume of 2,344,693. The stock has a market cap of $140.32 million, a P/E ratio of -0.22 and a beta of 0.52. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 7.48. MultiPlan has a twelve month low of $0.17 and a twelve month high of $1.91. The company has a 50 day moving average price of $0.31 and a 200-day moving average price of $0.55. MultiPlan (NYSE:MPLN - Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. The business had revenue of $233.48 million during the quarter, compared to the consensus estimate of $253.59 million. MultiPlan had a negative return on equity of 8.90% and a negative net margin of 122.73%. During the same quarter in the previous year, the company posted ($0.06) EPS. On average, research analysts forecast that MultiPlan will post -0.18 earnings per share for the current year. ## Analyst Ratings Changes Separately, Piper Sandler reissued a "neutral" rating and issued a $1.00 target price (down previously from $2.00) on shares of MultiPlan in a research note on Wednesday, August 7th. **Get Our Latest Stock Report on MultiPlan** ## Insider Activity at MultiPlan In other MultiPlan news, CFO Douglas Michael Garis purchased 1,150,000 shares of the stock in a transaction on Tuesday, August 6th. The stock was bought at an average price of $0.30 per share, for a total transaction of $345,000.00. Following the acquisition, the chief financial officer now directly owns 4,721,428 shares of the company's stock, valued at $1,416,428.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other MultiPlan news, CEO Travis Dalton purchased 500,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was bought at an average price of $0.37 per share, for a total transaction of $185,000.00. Following the acquisition, the chief executive officer now directly owns 5,004,504 shares of the company's stock, valued at $1,851,666.48. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Douglas Michael Garis purchased 1,150,000 shares of the stock in a transaction on Tuesday, August 6th. The stock was acquired at an average price of $0.30 per share, with a total value of $345,000.00. Following the acquisition, the chief financial officer now directly owns 4,721,428 shares in the company, valued at $1,416,428.40. The disclosure for this purchase can be found here. In the last quarter, insiders bought 1,731,165 shares of company stock valued at $555,161. 8.20% of the stock is owned by insiders. ## Institutional Trading of MultiPlan Several hedge funds and other institutional investors have recently added to or reduced their stakes in MPLN. Charles Schwab Investment Management Inc. grew its holdings in shares of MultiPlan by 6.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,522,486 shares of the company's stock worth $12,272,000 after purchasing an additional 482,944 shares during the period. Empowered Funds LLC grew its holdings in shares of MultiPlan by 98.8% during the 1st quarter. Empowered Funds LLC now owns 1,550,620 shares of the company's stock worth $1,258,000 after purchasing an additional 770,826 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of MultiPlan by 68.8% during the 1st quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 45,653 shares of the company's stock worth $37,000 after purchasing an additional 18,603 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of MultiPlan by 19.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 407,105 shares of the company's stock worth $331,000 after purchasing an additional 66,172 shares during the period. Finally, Fore Capital LLC purchased a new stake in shares of MultiPlan during the 2nd quarter worth about $37,000. Hedge funds and other institutional investors own 87.15% of the company's stock. ## MultiPlan Company Profile (Get Free Report) MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. ## Further Reading - Five stocks we like better than MultiPlan - How to Calculate Retirement Income: MarketBeat’s Calculator - Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead - What Investors Need to Know to Beat the Market - GameStop: Earnings Won’t Save It, Dilution Points to Trouble - Profitably Trade Stocks at 52-Week Highs - Dividend Aristocrats or Dividend Kings: Which Is Best for You? *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* → Trillion Dollar Blockchain Shift Could Trigger THIS Coin (From Crypto 101 Media) (Ad)## Should you invest $1,000 in MultiPlan right now? Before you consider MultiPlan, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list. While MultiPlan currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MPLN.US - MultiPlan](https://longbridge.com/en/quote/MPLN.US.md) - [CTEV.US - Claritev](https://longbridge.com/en/quote/CTEV.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 美股盘中速递：Claritev 跌 11.86%，成交量放大，板块波动性引发市场关注 | Claritev 跌 11.86%；Veeva Systems -CL 涨 1.40%，成交额达到 2.25 亿美元；Doximity 涨 5.84%，成交额达到 84.15 百万美元；Waystar 涨 1.35%，成交额达到 41.69 | [Link](https://longbridge.com/en/news/271557551.md) | | MultiPlan 在 1 月 10 日发现了对'Multi'应用程序数据库的未授权访问 | 巴西多元房地产公司（Multiplan Empreendimentos Imobiliarios SA）表示，1 月 10 日发现 “MULTI” 应用程序数据库遭到未授权访问 - 声明称，巴西多元房地产公司表示，该未授权访问已被迅速中断 | [Link](https://longbridge.com/en/news/273273476.md) | | Claritev Corporation 与 Kinetiq Health 合作，旨在提升医疗成本管理 | Claritev Corporation 已与 Kinetiq Health 达成合作，以增强医疗成本管理。这一战略合作将整合 Kinetiq Health 的风险管理服务与 Claritev 的 BenInsights 分析平台。目标是帮 | [Link](https://longbridge.com/en/news/273228246.md) | | Claritev 公司在医疗保健会议上发布了投资者演示文稿 | Claritev Corp 于 2026 年 1 月 15 日在摩根大通第 44 届年度医疗会议上进行了投资者演示。该公司旨在提高医疗透明度和可负担性，为健康计划成员识别出 247 亿美元的潜在节省。Claritev 服务于超过 6000 | [Link](https://longbridge.com/en/news/272700004.md) | | Claritev 公司将在摩根大通医疗健康大会上发表演讲 \| CTEV 股票新闻 | Claritev Corporation（纽约证券交易所代码：CTEV）将于 2026 年 1 月 15 日上午 7:30（太平洋时间）在第 44 届摩根大通医疗健康大会上进行演讲。该演讲将在公司的投资者关系网站上通过直播网络播出。Clar | [Link](https://longbridge.com/en/news/271634076.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.